“We have a plan for antimicrobial resistance. We have set up a surveillance system, also connected to Covid, which talks about case studies, monitoring, sequencing of epidemiological situations and also environmental levels, for risk management. And this plan is a great opportunity to translate, once the pandemic is over, also towards antimicrobial resistance. And there is also the issue of risk management, we are evaluating the effectiveness of the measures adopted during the pandemic, and this is one of the scientific approaches necessary to understand if the choices we make have an impact. It is important to have professionals always ready to face the emergency “. This was stated by ISS president Silvio Brusaferro speaking at an event organized by The European House – Ambrosetti (DIRECT) with contributions from Pfizer and bioMérieux, entitled “Planetary and Amr. Towards a new strategy to address global health challenges”.
“We need to open a new season of investments for the National Health Service. And try to have a new vision, the One Health strategy, the one that brings together humans, the environment and animals is the right one. Antimicrobial resistance is today’s theme, We have to invest in research. We have to work together, with synergies between public and private. Vaccines, the achievements of the last few months are the extraordinary result of synergies. We have to systematize the potential of research, together with the activities of the private sector with the public. To reverse the crisis of this time into an opportunity to relaunch: the conditions are there. We need a global pact as we are doing with the G20 for a global restart “. Health Minister Roberto Speranza said in a message at an event organized by The European House – Ambrosetti with the contribution of Pfizer and bioMérieux, entitled “Planetary and Amr. Towards a new strategy to face global health challenges” .
In renewal plan on antibiotic resistance
From the point of view of the use of antibiotics, continued Brusaferro, “based on the data, Italy has significant margins for improvement and presents a great difference between regions. It has a plan to combat the antibiotic resistance that we are renewing and we have a series of tools, also developed in the pandemic, that can help in the future “.
To counteract antibiotic resistance, or the proliferation of bacteria that are increasingly resistant to drugs, “we must tackle the problem not only from a human, but also from an environmental and animal point of view, based on the concept of One Health. Health is unique. and this is a great lesson from the pandemic. “